Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EPTIFIBATIDE injection safely and effectively. See full prescribing information for EPTIFIBATIDE injection. EPTIFIBATIDE injection, for intravenous useInitial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
Eptifibatide Injection is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (unstable angina [UA]/non-ST-elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those undergoing percutaneous coronary intervention (PCI). Eptifibatide Injection is indicated to decrease the rate of a combined endpoint of death, new MI, or need for urgent intervention in patients undergoing PCI, including those undergoing intracoronary stenting [see Clinical Studies (14.1, 14.2)].
- generic_name
- eptifibatide
- product_names
- eptifibatide
- ndc
- 25021-408, 25021-408-51, 25021-409, 25021-409-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en